These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1469629

  • 1. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
    Monnet FP, Fournier A, Debonnel G, de Montigny C.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
    Monnet FP, Debonnel G, Fournier A, de Montigny C.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1219-25. PubMed ID: 1469630
    [Abstract] [Full Text] [Related]

  • 3. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP, Carvalho AP, Carvalho CM, Malva JO.
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [Abstract] [Full Text] [Related]

  • 4. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR, Miller RJ, Rhim H, Maclean D, Georgic LM, MacKenzie RG, Grundemar L.
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [Abstract] [Full Text] [Related]

  • 5. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
    Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD.
    Eur J Neurosci; 1993 Dec 01; 5(12):1622-37. PubMed ID: 8124516
    [Abstract] [Full Text] [Related]

  • 6. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa.
    Bernet F, Maubert E, Bernard J, Montel V, Dupouy JP.
    Regul Pept; 1994 Aug 04; 52(3):187-93. PubMed ID: 7800851
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.
    Greber S, Schwarzer C, Sperk G.
    Br J Pharmacol; 1994 Nov 04; 113(3):737-40. PubMed ID: 7858862
    [Abstract] [Full Text] [Related]

  • 8. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS, Buckingham R, Williams G.
    Brain Res; 1997 Dec 05; 778(1):242-50. PubMed ID: 9462897
    [Abstract] [Full Text] [Related]

  • 9. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
    Widdowson PS.
    Brain Res; 1993 Dec 17; 631(1):27-38. PubMed ID: 8298993
    [Abstract] [Full Text] [Related]

  • 10. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
    Palea S, Corsi M, Rimland JM, Trist DG.
    Br J Pharmacol; 1995 May 17; 115(1):3-10. PubMed ID: 7647980
    [Abstract] [Full Text] [Related]

  • 11. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.
    Dumont Y, Cadieux A, Pheng LH, Fournier A, St-Pierre S, Quirion R.
    Brain Res Mol Brain Res; 1994 Oct 17; 26(1-2):320-4. PubMed ID: 7854062
    [Abstract] [Full Text] [Related]

  • 12. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML.
    Endocrinology; 1999 Sep 17; 140(9):4046-55. PubMed ID: 10465275
    [Abstract] [Full Text] [Related]

  • 13. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro.
    Klapstein GJ, Colmers WF.
    J Neurophysiol; 1997 Sep 17; 78(3):1651-61. PubMed ID: 9310450
    [Abstract] [Full Text] [Related]

  • 14. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
    Monnet FP, Debonnel G, Bergeron R, Gronier B, de Montigny C.
    Br J Pharmacol; 1994 Jun 17; 112(2):709-15. PubMed ID: 8075892
    [Abstract] [Full Text] [Related]

  • 15. Depressor effect of intrathecal neuropeptide Y (NPY) Is mediated by Y2 subtype of NPY receptors.
    Chen X, Westfall TC.
    J Cardiovasc Pharmacol; 1993 May 17; 21(5):720-4. PubMed ID: 7685440
    [Abstract] [Full Text] [Related]

  • 16. Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.
    Bijak M.
    Neurosci Lett; 1999 Jun 25; 268(3):115-8. PubMed ID: 10406018
    [Abstract] [Full Text] [Related]

  • 17. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.
    Xia J, Neild TO, Kotecha N.
    Br J Pharmacol; 1992 Nov 25; 107(3):771-6. PubMed ID: 1472974
    [Abstract] [Full Text] [Related]

  • 18. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
    Tschöpl M, Miller RC, Pelton J, Stoclet JC, Bucher B.
    Br J Pharmacol; 1993 Nov 25; 110(3):1098-104. PubMed ID: 8298798
    [Abstract] [Full Text] [Related]

  • 19. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
    Gehlert DR, Gackenheimer SL, Schober DA.
    Neurochem Int; 1992 Jul 25; 21(1):45-67. PubMed ID: 1303142
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
    Haynes JM, Hill SJ, Selbie LA.
    Br J Pharmacol; 1997 Dec 25; 122(7):1530-6. PubMed ID: 9421306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.